Search Orphan Drug Designations and Approvals
-
Generic Name: | Re188 P2045 somatostatin peptide analogue |
---|---|
Date Designated: | 06/19/2014 |
Orphan Designation: | Treatment of pancreatic cancer. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Andarix Pharmaceuticals, Inc. 141 Powderhouse Blvd Suite 1 Somerville, Massachusetts 02144 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-